Clinical Scorecard: Examining the Link Between Asthma and Glioma: Findings from a Case-Control Study in a Universal Healthcare Setting
At a Glance
Category
Detail
Condition
Malignant glioma and asthma
Key Mechanisms
Asthma-associated immune response, particularly elevated IgE levels, may enhance immune effector cell function protecting against pre-cancerous cells
Target Population
Department of War Military Health System beneficiaries including active-duty servicemembers, retirees, and dependents
Care Setting
Universal healthcare setting within the Military Health System
Key Highlights
Malignant gliomas are the most common and deadly malignant brain tumors with poorly understood etiology beyond genetic factors and ionizing radiation.
Previous studies on asthma and glioma risk have methodological limitations including reliance on self-reported asthma and potential detection bias.
This study used medical record-confirmed asthma diagnoses and matched controls to reduce recall and detection biases, leveraging a large universal healthcare database.
Guideline-Based Recommendations
Diagnosis
Use medical records and ICD codes to confirm asthma diagnosis rather than self-report to reduce misclassification.
Diagnose glioma using pathology confirmation and ICD-O-3 morphology and topography codes.
Management
No direct management recommendations for asthma or glioma from this study; focus is on epidemiological association.
Monitoring & Follow-up
Consider potential detection bias in patients with asthma due to increased medical surveillance when monitoring for glioma.
Risks
Ionizing radiation is a recognized risk factor for malignant glioma.
Potential misclassification and detection biases can affect assessment of asthma’s association with glioma risk.
Patient & Prescribing Data
DoW Military Health System beneficiaries with universal healthcare access
Not applicable; study focused on epidemiological association rather than treatment outcomes.
Clinical Best Practices
Confirm asthma diagnosis using objective medical records and ICD coding to minimize recall bias.
Use matched controls including MRI-negative controls to reduce detection bias in case-control studies of glioma.
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from March 16 - 31.
